Company / Total Assets
bioAffinity Technologies, Inc. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$11.0M
FY2025
5-year range
$6.5M / $12.2M
FY2022-FY2025
Trend
+68.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $11M.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of -3.5%.
Improved from $8M to $11M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -3.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -3.5%, indicating a declining trend.
- In FY2025, total assets increased 68.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.0M | +68.3% |
| FY2024 | $6.5M | -20.8% |
| FY2023 | $8.2M | -32.5% |
| FY2022 | $12.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026